A Study of CX157 (TriRima) for the Treatment of Depression
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Major Depressive Disorder
Related studies linked through entity extraction aliases.
Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE2
Creatine Augmentation Treatment in Major Depressive Disorder Subjects
- Status
- COMPLETED
- Phase
- NA
Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
- Status
- COMPLETED
- Phase
- PHASE4
Cysteamine Therapy for Major Depressive Disorder
- Status
- TERMINATED
- Phase
- NA
Fluoxetine vs. Brief Psychotherapy for Major Depression
- Status
- COMPLETED
- Phase
- NA
Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Exploring a Potential Blood Test to Diagnose Major Depressive Disorder
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE2
Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
- Status
- COMPLETED
- Phase
- PHASE4
Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
- Status
- COMPLETED
- Phase
- PHASE3
International Study to Predict Optimised Treatment - in Depression
- Status
- UNKNOWN
- Phase
- PHASE4
TC-5214 as add-on the Treatment of Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE2
Quetiapine in Co-Morbid Depressive and Anxiety Disorders
- Status
- COMPLETED
- Phase
- NA
A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder
- Status
- COMPLETED
- Phase
- PHASE3